Skip to content

Becton Dickinson and Company Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 5, 2026 results vs estimates

Becton Dickinson and Company · E.BDX.NYSE · United States
Use symbol E.BDX.NYSE in our API & Excel add-in to retrieve this data ↓
198.34
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 22.02%

Becton Dickinson and Company Forecast

Becton Dickinson and Company short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 22.0% a year, a typical one-standard-deviation range is 192.19–204.49 over a week, 185.73–210.95 over a month and 154.67–242.01 over a year. (Signals as of 1 Nov 2026.)

Becton Dickinson and Company Price Chart

MacroFinance.ai

Becton Dickinson and Company Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Becton Dickinson and Company
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Becton Dickinson and Company
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Becton Dickinson and Company
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Becton Dickinson and Company
P/E
47.51x
Mid-range vs own history
QoQ −15.4%
YoY +36.1%
now 47.513424.29 low58.16 high
ⓘP/E As of 22 Nov 2026.See Becton Dickinson and Company returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Becton Dickinson and Company
P/S
2.69x
Mid-range vs own history
QoQ +6.0%
YoY +3.8%
now 2.68781.88 low2.95 high
ⓘP/S As of 22 Nov 2026.See Becton Dickinson and Company returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Becton Dickinson and Company
P/B
2.20x
Mid-range vs own history
QoQ +1.8%
YoY +1.3%
now 2.20221.67 low2.42 high
ⓘP/B As of 22 Nov 2026.See Becton Dickinson and Company returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Becton Dickinson and Company
EV/EBITDA
14.92x
Cheap vs own history
QoQ −4.5%
YoY −3.3%
now 14.918412.35 low16.28 high
ⓘEV/EBITDA As of 22 Nov 2026.See Becton Dickinson and Company returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Becton Dickinson and Company
EV/Sales
3.46x
Mid-range vs own history
QoQ +4.6%
YoY +0.1%
now 3.45982.66 low3.73 high
ⓘEV/Sales As of 22 Nov 2026.See Becton Dickinson and Company returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Becton Dickinson and Company
FCF Yield
5.1%
Mid-range vs own history
QoQ +3.2%
YoY +10.5%
now 5.09064.43 low7.8 high
ⓘFCF Yield As of 22 Nov 2026.See Becton Dickinson and Company returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Becton Dickinson and Company
Earnings Yield
2.1%
Mid-range vs own history
QoQ +18.2%
YoY −26.5%
now 2.10471.72 low4.12 high
ⓘEarnings Yield As of 22 Nov 2026.See Becton Dickinson and Company returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Becton Dickinson and Company
Dividend Yield
2.1%
Mid-range vs own history
QoQ −3.7%
YoY +0.7%
now 2.13591.94 low2.94 high
ⓘDividend Yield As of 22 Nov 2026.See Becton Dickinson and Company returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Becton Dickinson and Company
Market Cap
$54.4B
Mid-range vs own history
QoQ +2.9%
YoY −1.8%
now 54355.275340,263 low60,301 high
ⓘMarket Cap As of 22 Nov 2026.See Becton Dickinson and Company returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Becton Dickinson and Company
Net Debt
$15.6B
Mid-range vs own history
QoQ −3.0%
YoY −16.0%
now 1561215,612 low18,504 high
ⓘNet Debt As of 22 Nov 2026.See Becton Dickinson and Company returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Becton Dickinson and Company
Net Debt / EBITDA
3.33x
Mid-range vs own history
QoQ −8.8%
YoY −14.2%
now 3.32883.33 low3.79 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Becton Dickinson and Company returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Becton Dickinson and Company
Current Ratio
0.87x
Weak vs own history
QoQ +0.7%
YoY −21.0%
now 0.87150.87 low1.11 high
ⓘCurrent Ratio As of 22 Nov 2026.See Becton Dickinson and Company returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Becton Dickinson and Company
Quick Ratio
0.54x
Weak vs own history
QoQ +4.7%
YoY −13.2%
now 0.53710.51 low0.64 high
ⓘQuick Ratio As of 22 Nov 2026.See Becton Dickinson and Company returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Becton Dickinson and Company
Interest Coverage
4.35x
Mid-range vs own history
QoQ +22.8%
YoY +6.6%
now 4.34753.54 low4.35 high
ⓘInterest Coverage As of 22 Nov 2026.See Becton Dickinson and Company returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Becton Dickinson and Company
Debt / Equity
0.66x
Mid-range vs own history
QoQ −3.8%
YoY −12.8%
now 0.66220.66 low0.77 high
ⓘDebt / Equity As of 22 Nov 2026.See Becton Dickinson and Company returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Becton Dickinson and Company
Piotroski F-Score
6
Mid-range vs own history
QoQ −14.3%
YoY −14.3%
now 66 low7 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Becton Dickinson and Company returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
  18 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  19 members-only factors: Sloan Accruals, Cash-Earnings Gap, Days Sales in Receivables Index, Gross Margin Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Becton Dickinson and Company, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Becton Dickinson and Company fundamentals: income statement, balance sheet & cash flow

Becton Dickinson and Company reported revenue of $19.46bn and net income of $1.15bn in FY2026, the year ended 30 September 2026 — revenue down 10.9% and net income down 31.7% on the prior year. Free cash flow was $2.69bn. These figures are as reported in the filings, not restated: 42 fiscal years and 165 quarters of history, back to September 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2026)
$19.46bn
-10.9%
Net income
$1.15bn
-31.7%
Gross margin
47.36%
Free cash flow
$2.69bn
+0.9%
Net debt
$15.62bn
Shares short (30 Oct 2026)
8.11m
5.20 days to cover
Becton Dickinson and Company income statement, annual, as reported · USD billions unless stated
USD billionsFY2026FY2025FY2024FY2023FY2022
Period end30 Sep 202630 Sep 202530 Sep 202430 Sep 202330 Sep 2022
Revenue19.4621.8420.1819.3718.87
Cost of revenue10.2411.9211.0511.2010.39
Gross profit9.219.929.138.178.48
Research & development0.991.261.191.241.26
Operating income2.262.582.402.112.28
EBITDA4.614.964.824.404.41
Interest expense0.560.610.530.450.40
Pre-tax income1.811.882.011.661.78
Income tax0.390.200.300.130.15
Net income1.151.681.711.481.78

Download Becton Dickinson and Company fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.BDX.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 42 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Becton Dickinson and Company

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Becton Dickinson and Company Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Becton Dickinson and Company; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Becton Dickinson and Company’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Becton Dickinson and Company behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Becton Dickinson and Company (United States)

Becton Dickinson and Company is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on BCAL Diagnostics Ltd

Frequently asked questions

What is Becton Dickinson and Company?
Becton Dickinson and Company is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Becton Dickinson and Company price?
The latest close is 198.34 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Becton Dickinson and Company in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Becton Dickinson and Company?
20-day realised volatility is 22.0% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 6.4% over a month and 3.1% over a week.
What factors affect Becton Dickinson and Company?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Becton Dickinson and Company, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Becton Dickinson and Company?
58 backtested tactical asset allocation strategies trade Becton Dickinson and Company through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Becton Dickinson and Company returns analysed?
The Statistical Distribution of Returns section shows the distribution of Becton Dickinson and Company daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Becton Dickinson and Company historical data?
In the Free historical data section of this page: the last 10 years of Becton Dickinson and Company daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Becton Dickinson and Company historical data (last 10 years)

Browse or instantly download the last 10 years of Becton Dickinson and Company daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.BDX.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20212.78
2026-11-19212.68
2026-11-18216.08
2026-11-17215.42
2026-11-16216.47
2026-11-13218.03
2026-11-12215.71
2026-11-11214.52
2026-11-10212.61
2026-11-09215.25
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.